448

Compound name
Dacomitinib
Alt Name
PF-00299804
PF299804
Compound Image
Dacomitinib.png
SMILES
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
MW
469.90
Brutto
C24H25ClFN5O2
InChI
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
InChI Key
LVXJQMNHJWSHET-AATRIKPKSA-N
Approval Jurisdiction
2018 FDA 2019 EMA
Approved for clinical use
NSCLC With EGFR Mutations
CAS
1110813-31-4
PubChem CID
11511120
Action
mutant EGFR
Approved Drug List
1
Commercial Vendor
Pfizer